Osaic Holdings’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Other funds holding CLDX
KCM
BBA
Osaic Holdings's CLDX Position: Q3 2026 in Review
Osaic Holdings increased its Celldex Therapeutics (CLDX) stake by 82% in Q3 2026, buying an estimated $27.2K and bringing the position to 1,572 shares worth $50.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5501.
Osaic Holdings first reported a position in CLDX in Q1 2020 and has held it in 27 quarters since. 249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.
- Osaic Holdings held 1,572 shares of Celldex Therapeutics worth $50.7K as of Q3 2026.
- Osaic Holdings bought 710 Celldex Therapeutics shares in Q3 2026, an estimated $27.2K.
- Celldex Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #5501 holding.
- Osaic Holdings first reported a position in Celldex Therapeutics in Q1 2020 and has held it in 27 quarters since.
- 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.